Sucralfate alleviating post-laser-assisted uvulopalatoplasty pain.
Laser-assisted uvulopalatoplasty (LAUP) is an outpatient mode of treatment for snoring and perhaps for some mild cases of obstructive sleep apnea syndrome. LAUP results in severe throat pain that usually lasts for 8 to 14 days. Sucralfate adheres to proteins at the duodenal ulcer site, forming a protective coating against gastric acid, pepsin, and bile salts, that promotes healing. If a similar protective coating could be created at the area of LAUP trauma, morbidity may be diminished. Twenty-eight patients have undergone LAUP treatment-2 with mild obstructive sleep apnea syndrome and 26 with simple snoring. A block-randomized, single blind clinical study was performed. Sucralfate was administered in 14 patients (group A) every 6 hours for 15 days as a swish and swallow, whereas the other 14 patients (group B) received water for injection with a strawberry flavor as placebo with the same dosing. As a conclusion, sucralfate significantly lowered postoperative pain and the need for analgesic drug use as well as the total number of the days the patients needed to almost reach their normal diet quantity (> or = 80% of normal quantity).
Kyrmizakis
D E
DE
Ear Nose Throat Department of University Hospital, Heraklion, Crete, Greece.
Papadakis
C E
CE
Bizakis
J G
JG
Velegrakis
G A
GA
Siafakas
N M
NM
Helidonis
E S
ES
D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D013517:Otorhinolaryngologic Surgical Procedures / Q000379:methods*; D010147:Pain Measurement; D010149:Postoperative Pain / Q000175:diagnosis / Q000188:drug therapy*; D010160:Palate, Soft / Q000601:surgery*; D016037:Single-Blind Method; D020181:Sleep Apnea, Obstructive / Q000601:surgery*; D013392:Sucralfate / Q000627:therapeutic use*; D014609:Uvula / Q000601:surgery*
D000897:Anti-Ulcer Agents; D013392:Sucralfate